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Background: Gated Volumetric Modulated Arc Therapy (VMAT) is an emerging radiation therapy modality for
treatment of tumors affected by respiratory motion. However, gating significantly prolongs the treatment time, as
delivery is only activated during a single respiratory phase. To enhance the efficiency of gated VMAT delivery, a
novel dual-gated VMAT (DG-VMAT) technique, in which delivery is executed at both exhale and inhale phases in a
given arc rotation, is developed and experimentally evaluated.
Methods: Arc delivery at two phases is realized by sequentially interleaving control points consisting of MUs, MLC
sequences, and angles of VMAT plans generated at the exhale and inhale phases. Dual-gated delivery is initiated
when a respiration gating signal enters the exhale window; when the exhale delivery concludes, the beam turns off
and the gantry rolls back to the starting position for the inhale window. The process is then repeated until both
inhale and exhale arcs are fully delivered. DG-VMAT plan delivery accuracy was assessed using a pinpoint chamber
and diode array phantom undergoing programmed motion.
Results: DG-VMAT delivery was experimentally implemented through custom XML scripting in Varian’s TrueBeam™
STx Developer Mode. Relative to single gated delivery at exhale, the treatment time was improved by 95.5% for a
sinusoidal breathing pattern. The pinpoint chamber dose measurement agreed with the calculated dose within
0.7%. For the DG-VMAT delivery, 97.5% of the diode array measurements passed the 3%/3 mm gamma criterion.
Conclusions: The feasibility of DG-VMAT delivery scheme has been experimentally demonstrated for the first time.
By leveraging the stability and natural pauses that occur at end-inspiration and end-exhalation, DG-VMAT provides
a practical method for enhancing gated delivery efficiency by up to a factor of two.
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Respiratory induced tumor motion is the major com-
plicating factor in radiotherapy of thoracic and upper
abdominal targets. A variety of techniques have been
developed for the clinical management of organ motion,
each with distinct advantages and drawbacks [1-5]. These
techniques can be generally categorized in order of ap-
proximate increased technical complexity as motion
encompassing irradiation, breath-hold methods, compres-
sion methods, gating methods, and dynamic tracking
methods. Among these, gating methods have gained clin-
ical traction as they limit the volume of normal tissue irra-
diated relative to motion encompassing irradiation, yet
provide a reliable and a technical feasible alternative to
continuous tracking irradiation [6-11].* Correspondence: lei@stanford.edu
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unless otherwise stated.With improvements in dynamic delivery, Volumetric
Modulated Arc Therapy (VMAT) has emerged as an
efficient alternative to static field Intensity Modulated
Radiotherapy (IMRT) for producing highly conformal
dose distributions [12-14]. More recently, gated VMAT
has been implemented for treating tumors influenced
by respiratory motion by restricting the arc delivery to
a single stable portion of the respiratory cycle, such as
the end-of-exhale (EOE) phase. While gated VMAT is
a promising technique, since the delivery is restricted
to a narrow segment of the respiration, the treatment
time is significantly increased, which depending on the
width of the gating window, can result as much as 5.5
times relative elongation of the treatment time relative
to non-gated treatments [15,16]. Prolonged treatment
time can result in dosimetric inaccuracy, baseline shift,
increased patient discomfort, degradation of radiobiological
efficacy, and reduction of clinical throughput. More-
over, improving gated delivery efficiency is of particularal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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because of the already protracted delivery associated with
large dose fractions. In general, gating window selection is a
compromise between the residual tumor movement within
the gating window and dose delivery time. Because there is
generally relatively little residual tumor motion within the
end-of-exhale (EOE) phase [7], the EOE window is often
selected for gating. However, the end-of-inhale (EOI) phase
is also relatively stable, and can be dosimetrically advan-
tageous in certain cases [8-10]. A delivery scheme that
enables beam-on during both EOE and EOI would make
it possible to combine the delivery advantages of both
phases. It is noted that, while theoretically, continuous
tracking delivery has the potential for full duty cycle ef-
ficiency [17], due to stringent technical demands, and
more importantly, clinical concerns in accurately pre-
dicting and irradiating the more variable portions of the
breathing cycle in-between the more stable exhale and
inhale, its clinical application on a conventional multi-
leaf collimator linac has been limited. For these reasons,
a simple and technically practical solution for enhancing
gated delivery that irradiates only the clinically reliable
portions of the breathing cycle is desirable.
To address the limitations in efficiency of gated VMAT,
in this work we introduce and demonstrate Dual-Gated
VMAT (DG-VMAT) – a method that alternatively delivers
dose at both the inhale and exhale phases during a VMAT
delivery. While gating on a single phase is currently imple-
mentable on most modern linacs gating on more than a
single phase requires the synchronization of the MLCs
and gantry motion to the different locations of the target
at the two different phases of the respiratory cycle. A
practical approach to such an implementation is pre-
sented, and the feasibility is demonstrated by experimen-




The design of DG-VMAT is complicated by the fact that
both the MLC motion and the gantry motion must be
coupled and synchronized with two different portions of
the respiratory cycle. A practical solution to this is pro-
vided through the scheme shown in Figure 1. Given two
optimized plans corresponding separately to the exhale
(EOE) and inhale phases (EOI) of a representative trace
in Figure 1a, the dual-gated rotational arc delivery, as
described in the flowchart of Figure 1b, starts from the
initial node of one of the plans, taken here as the EOE
plan. After the initial EOE arc delivery segment, the
beam is turned off and the linac gantry rotates back with
the MLC assuming the starting position specified in the
EOI plan in preparation for the delivery. The first EOI
node is delivered, and since the gantry position atcompletion of the first EOI gate is the same as the start-
ing position of the EOE window of the second breathing
cycle, the gantry remains stationary during the transition
from EOI to EOE delivery. The alternating delivery
process continues until all the nodes or MUs are deliv-
ered. The resulting gantry motion is demonstrated in
Figure 1c, which highlights the rolling back and forth
of the gantry for the alternating delivery of the EOE
and EOI phases. The behavior of the gantry motion
and its relation to the beam delivery, as defined by the
cumulative monitor units, is plotted as function of time in
Figure 1d.
Treatment planning
The method necessitates two independent plans to be
optimized at the EOE and EOI phases using a 4DCT
simulation scan. In the feasibility study, an SBRT patient
case with a 4D planning CT and approximately 2 cm
superior-inferior tumor motion between EOE and EOI
was selected to demonstrate the DG-VMAT planning
and delivery process. Two independent VMAT treatment
plans were generated using Varian’s Eclipse treatment
planning system (Version 8.9); one for EOE and the other
for EOI, based on the respective exhale and inhale phase
images of the 4DCT scans. For each of the two plans, a
dose of 15 Gy was prescribed to the 95% of PTV volume,
and a full arc plan consisting of 177 segments (control
points) was optimized for the same dose prescription and
arc optimization criteria. 10 MV Flattering Filter Free
(FFF) beams were used for treatment planning. A fraction-
ation scheme 15 Gy in 3 was set for delivery.
Experimental implementation and dosimetric validation
DG-VMAT plan scheme in Figure 1 was experimentally
implemented for an SBRT plan using Developer Mode
XML scripting in the TrueBeam™ STx platform (Varian
Medical Systems, Palo Alto, CA), which enables pro-
grammed control of all system parameters. Using con-
trol points specifying the MLC leaf sequences and
MUs derived from the independent single phase plans,
a DG-VMAT delivery was programmed by sequentially
interleaving the control points of the EOE and EOI
plans, and enabling beam-on at the two corresponding
phases of the respiratory surrogate phase.
Dual-gated VMAT plans were delivered and validated by
running the formulated XML script, triggered by the RPM
infrared camera and reflector system affixed to the motion
platform (Varian Medical Systems, Palo Alto, CA). The de-
livered dose was measured by using a 0.015 cc PTW
N31014 pinpoint chamber (PTW, Freiburg, Germany) in
14 cm of solid water and a Delta 4 diode array (ScandiDos,
Uppsala, Sweden). Both the pinpoint chamber and Delta 4
phantom were placed on top of a motion platform, which
served to simulate breathing motion. A 2 cm motion in the
Figure 1 Cell proliferation measurements of MDA-MB-231 cells for control and LMMS groups assessed with a) Trypan Blue dye exclusion
method b) MTT assay. c) Number of MDA-MB-231 cells that were detached from the plastic counted by Trypan Blue stain. d) Cell proliferation of
MCF10A cells assessed with MTT assay. (*: p < 0.05 between LMMS and sham controls).
Fahimian et al. Radiation Oncology 2014, 9:209 Page 3 of 7
http://www.ro-journal.com/content/9/1/209
Fahimian et al. Radiation Oncology 2014, 9:209 Page 4 of 7
http://www.ro-journal.com/content/9/1/209superior-inferior direction with a period of 6 seconds was
utilized, with the inhale and exhale gating windows set at
25% of the full period. The measured dual-gated dose dis-
tribution was compared to the summed inhale and exhale
dose distributions computed using an Eclipse AAA version
8.9.08. The delivery time was measured and compared to
conventional single gated delivery, corresponding to the
EOE plan scaled to an equivalent total dose.
Results
Figure 2a and 2b show the dose distributions for the
EOE and EOI plans, respectively. A composite plan, con-
sisting of the EOI plan deformed doses imposed onto
EOE CT images and summed with EOE plan dose, is
presented in Figure 2c. The dose-volume histograms
(DVHs) for the conventional exhale-gated plans (solid
lines), and the dual-gated plan (dashed lines), are
depicted in Figure 2d as computed using MIM imaging
fusion software (MIM, Cleveland, OH). It is noted that
there is some variation in the coverage of the EOE and
EOI plans, which in addition to the errors and artifact of
the dose warping and image registration process, results
in variation in the estimated final DVHs [18]. In general,
the dosimetric variation of DG-VMAT versus conven-
tional single gated plans will depend on the patient anat-
omy on EOE and EOI phases, and the quality of the
plans for each phase.Figure 2 Isodose distributions of individual (a) EOE, (b) EOI, and (c) su
EOE gating plan (solid line) and deformed dose summation of the dual-gaFigure 3 displays the dosimetric comparison of delivery,
relative to the planned DG-VMAT plan using the diode
array. The deviations as analyzed using the a 3 mm/3%
gamma-test criterion; Figure 3a,b displays the passing
points in the two planes of the diode array, while the dose
profiles and the gamma histogram is shown in Figure 3c-e.
For the dual-gated delivery, 97.5% of the measurement
points pass the gamma-test criterion a gamma < 1. As indi-
cated by Figure 3a,b, the failed points were at the primarily
at periphery of the field in low dose regions. In addition to
the diode measurements, the pinpoint chamber absolute
dose measurement agreed with the dose calculation
within 0.7%.
The delivery time reduction was assessed through
comparison of the DG-VMAT delivery time with that of
the conventional EOE plan scaled to the same dose. The
conventional EOE gated VMAT delivery requires
346 seconds for the studied case, while the proposed
DG-VMAT technique is delivered in 177 seconds per frac-
tion. Thus, for this particular case, dual-gated VMAT pro-
vides a 95.5% improvement in delivery efficiency compared
to the corresponding single-gated delivery.
Discussion
Implementation of DG-VMAT requires the synchronization
of the gantry motion and MLC with two phases of the
respiratory cycle. As such, for half the transitions betweenmmed dual-gated plan. (d) Dose-volume histograms of the single
ted plan (dashed line).
Figure 3 Dosimetric validation of DG-VMAT using a diode array (a), (b) Display of the diodes passing the 3%/3 mm gamma test for the
two crossed plane diode arrays (c) Horizontal dose profile of dose plane in (a), (d) Vertical dose profile of dose plane in (b), (e)
Histogram of the gamma distribution.
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between the phases, as depicted in Figure 1c,d. This is shown
to be possible with the TrueBeam™ STx, which has a gantry
rotation speed of 6 degrees/second, and a MLC leaf speed of
2.5 cm/second at isocenter. The DG-VMAT delivery re-
quired a roll-back of an average of 2.05 degrees, which is
achieved in 0.34 seconds. Since the transition time between
exhale and inhale gating windows was 1.5 seconds, there was
more than sufficient time for the gantry and MLC to move
to the planned positions in preparation for the subse-
quent nodal delivery. Considering an average breathing
cycle of 4–6 seconds, such a motion is within the limits
of current linacs as demonstrated in this first experi-
mental demonstration.
While the results indicate that the treatment time may
be reduced by nearly a factor two for an ideal breathing
pattern, a number of issues must be considered for
implementation in a clinical setting. Most importantly is
the variability in breathing patterns of human subjects.
Specifically, it is known that under free breathing, subjects
may spend more time in the exhale phase than inhale. If
un-coached, a reduction of the magnitude of the efficiency
enhancement with dual gating may be expected. In the
current implementation of DG-VMAT, it is explicitly
assumed that there is 1:1 ratio between the EOI and EOE
gating window. To achieve this during a patient treatment,
coaching via audio-visual guidance must be used. Specific-
ally, the patient will be directed to briefly hold their breath
at inhale and exhale for equal time intervals that are known
from a simulation study to be comfortably tolerable for the
patient. Through audio-visual guidance, the patient will be
instructed on when to exit the EOI or EOE phase to
proceed to the next delivery node. Such a technique has
been experimentally shown to effectively equalize the inhale
and exhale phases in healthy human subjects by Geneser
et al. [19], as shown in Figure 4.
In this initial work, treatment planning was performed
with the inhale and exhale phase optimized independ-
ently of each other. 4D treatment planning [20-22] mayFigure 4 Dual-gated dynamics of a healthy individual under free brea
(bottom). The inhale and exhale gating windows are indicated by the lighbe adapted for a more cohesive optimization of the two
phases through which DVH parameters are simultan-
eously optimized.
Several observations on the limitations and advantages
of DG-VMAT can be made in relation to other respiratory
management techniques. DG-VMAT is technically more
complex than breath-hold techniques. Deep inspiration
breath hold may achieve more advantageous anatomical
separation for normal tissue sparing and has become more
feasible with the use of high dose-rate flattening-filter-free
beams [23,24]. However, prolonged breath holding, as
required to deliver SBRT doses, may not be tolerated by
portions of the patient population, specifically those with
already compromised lung function. Gating presents an
alternative solution for such patients. Gating however,
inherently results in significantly higher total treatment
times due the fact the beam is conventionally activated for
one phase of the breathing cycle. Dual gating, aims to
enhance the efficiency of gating. While the technical com-
plexity for such a delivery is higher than conventional
gating, it represents significant simplification of alternate
dynamic tracking proposals. More importantly, relative to
tracking, dual gating only utilizes the stable portions of
the respiratory cycle, and thereby eliminates intermediate
irradiation between exhale and inhale which is known to
be unstable and unpredictable.
Conclusions
To enhance the delivery efficiency of gated VMAT, a
technique for dual-gated delivery, leveraging the natural
pauses that occur at peak-inspiration and exhalation for
irradiation, has been proposed. The technique which
necessarily coordinates the gantry rotation and MLC
modulation with two different phases of respiratory
cycle was experimentally implemented using custom
XML programing in TrueBeam™ STx Developer Mode.
The results presented herein demonstrate the first suc-
cessful delivery of DG-VMAT which is shown to result
in nearly a doubling of treatment delivery efficiency forthing (top) and coached inhale and exhale breath-holds
t and dark green windows, respectively.
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mentation on patients, audio-visual guidance may be
used to coordinate the breathing with the delivery.
Dual-gated delivery efficiency can be further improved
with additional linac hardware and software modifications
to enable implementation in clinical mode. As compared
to the existing respiratory-gating VMAT technique, a
major advantage of DG-VMAT is that it substantially re-
duces treatment duration with a modest but practically
achievable increase in complexity of the treatment delivery
processes. DG-VMATcan potentially provide a comprom-
ise between breath-hold, gating, and tracking techniques
by increasing the tolerability relative to breath-hold, redu-
cing technical demand and potential inaccuracies associ-
ated with irradiation of variable portions of the respiratory
cycle relative to tracking techniques, and increasing the
efficiency of treatment relative to conventional single
window gating.
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